Magnusson P, Farley J R
Bone and Mineral Metabolic Unit, Division of Clinical Chemistry, Department of Biomedicine and Surgery, Linköping University Hospital, SE-581 85 Linköping, Sweden.
Calcif Tissue Int. 2002 Dec;71(6):508-18. doi: 10.1007/s00223-001-1137-4. Epub 2002 Sep 18.
High-performance liquid chromatography (HPLC) separates three human bone alkaline phosphatase (BALP) isoforms in serum; two major BALP isoforms, B1 and B2, and a minor fraction, B/I, which is composed on average of 70% bone and 30% intestinal ALP. The current studies were intended to identify an in vitro source of the BALP isoforms for physical, biochemical, and immunological characterizations. The three BALP isoforms were identified in extracts of human osteosarcoma (SaOS-2) cells, by HPLC, after separation by anion-exchange chromatography. All three BALP isoforms were similar with respect to freeze-thaw stability, solubility, heat inactivation, and inhibition by L-phenylalanine, L-homoarginine, and levamisole. The isoforms were also kinetically similar (i.e., maximal velocity and KM at pH 8.8 and pH 10.0). The isoforms differed, however, with respect to sensitivity to precipitation with wheat germ agglutinin (WGA), P < 0.001, but not Concanavalin A. At 3.0 mg/ml, WGA precipitated approximately 25% of B/I but more than 80% of B1 and B2. Molecular weights were estimated by native gradient gel electrophoresis: B/I, 126 kDa; B1, 136 kDa; and B2, 141 kDa. Desialylation with neuraminidase reduced the apparent sizes of B1 and B2 to 127 kDa (i.e., approximately to that of B/I). The total carbohydrate content was calculated to be 18 kDa, 28 kDa, and 33 kDa (i.e., 14%, 21%, and 23%) for the BALP isofonns, B/I, B1, and B2, respectively. The number of sialic acid residues was estimated to be 29 and 45, for each B1 and B2 homodimer, respectively. Apparent discrepancies between these estimates of molecular weight and estimates based on gel filtration chromatography were attributed to nonspecific interactions between carbohydrate residues and the gel filtration beads. All three BALP isoforms showed similar dose-dependent linearity in the commercial Alkphase-B and Tandem-MP Ostase immunoassays, r = 0.944 and r = 0.985, respectively (P < 0.001). In summary, our data indicate that B1 and B2 have more (or more reactive) sialic acid residues compared with B/I, which mainly explains the apparent differences in molecular weight. Future investigations will focus on the clinical and functional significance of the revealed differences in sialic acid residues.
高效液相色谱法(HPLC)可分离血清中的三种人骨碱性磷酸酶(BALP)同工型;两种主要的BALP同工型,即B1和B2,以及一小部分B/I,其平均由70%的骨碱性磷酸酶和30%的肠碱性磷酸酶组成。当前的研究旨在确定用于物理、生化和免疫特性鉴定的BALP同工型的体外来源。通过阴离子交换色谱分离后,经HPLC在人骨肉瘤(SaOS-2)细胞提取物中鉴定出了这三种BALP同工型。就冻融稳定性、溶解性、热失活以及L-苯丙氨酸、L-高精氨酸和左旋咪唑的抑制作用而言,所有三种BALP同工型均相似。这些同工型在动力学上也相似(即在pH 8.8和pH 10.0时的最大速度和米氏常数)。然而,这些同工型在对麦胚凝集素(WGA)沉淀的敏感性方面存在差异,P<0.001,但对刀豆球蛋白A不敏感。在3.0mg/ml时,WGA沉淀了约25%的B/I,但沉淀了超过80%的B1和B2。通过天然梯度凝胶电泳估计分子量:B/I为126kDa;B1为136kDa;B2为141kDa。用神经氨酸酶去唾液酸处理使B1和B2的表观大小降至127kDa(即约为B/I的大小)。计算得出BALP同工型B/I、B1和B2的总碳水化合物含量分别为18kDa、28kDa和33kDa(即14%、21%和23%)。估计每个B1和B2同二聚体的唾液酸残基数量分别为29个和45个。这些分子量估计值与基于凝胶过滤色谱法的估计值之间明显的差异归因于碳水化合物残基与凝胶过滤珠之间的非特异性相互作用。在商业Alkphase-B和Tandem-MP Ostase免疫测定中,所有三种BALP同工型均显示出相似的剂量依赖性线性,r分别为0.944和0.985(P<0.001)。总之,我们的数据表明,与B/I相比,B1和B2具有更多(或更具反应性)的唾液酸残基,这主要解释了分子量上的明显差异。未来的研究将集中于所揭示的唾液酸残基差异的临床和功能意义。